The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.16
Bid: 4.14
Ask: 4.78
Change: -0.25 (-5.67%)
Spread: 0.64 (15.459%)
Open: 4.16
High: 4.16
Low: 4.16
Prev. Close: 4.41
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trial Results

2 Feb 2010 07:00

RNS Number : 5003G
Plant Health Care PLC
02 February 2010
 



2 February, 2010

 

Plant Health Care plc ("Plant Health Care" or "the Company")

 

PLANT HEALTH CARE REPORTS VERY ENCOURAGING RESULTS

WITH BOTH MYCONATE AND HARPINS IN SUGARCANE

 

Plant Health Care (AIM: PHC), a leading provider of naturally derived products to the agriculture and landscape industries announces that its wholly owned subsidiary, Plant Health Care Inc, has achieved very encouraging results in an independent field trial of its Myconate and harpin products on sugarcane in Louisiana, USA.

 

The Plant Health Care board believes that these results further demonstrate the potential of Plant Health Care's two key technologies in another important global food and energy crop.

 

The field trial is the first of a series Plant Health Care has planned for sugarcane. In the trial, Myconate and harpin were applied, both separately and combined, as an in-furrow spray over the cane stalk segments at planting time before being covered with soil. In another treatment, harpin was applied as a post-emergent foliar spray to the growing plants. All treatments increased the number of productive plants and stems per acre, boosted plant height through to harvest and increased cane yield by between 8% and 12% over that of an untreated control. In addition, the yield of sugar per ton of cane was increased such that the final result was a boost in sugar production per acre of 19% - 23% depending upon the treatment. All results were statistically significant.

 

Plant Health Care's novel Myconate technology helps crops to develop a larger root mass enabling treated crops to prosper under stressful conditions. Myconate works by triggering the colonisation of plant roots by beneficial microorganisms called mycorrhizal fungi. With more mycorrhizal fungi at work, each plant can draw more nutrients and moisture out of the soil. The harpin technology offers benefits, including the suppression of pests like nematodes and yield-inhibiting diseases, as well as additive plant health benefits. The technology is a specific protein that activates a plant's innate ability to protect itself and enhance growth and yield.

 

John Brady, CEO of Plant Health Care commented: "We are very pleased with the outcome of this first test and are hopeful that these results will be repeated over seasons, locations and varieties as we apply more focus to this crop. These results come at a time when major seed and agricultural chemical companies are giving greater attention to sugarcane. The crop is not only an important source of sugar products for humans and animal nutrition but is also the crop upon which the successful bio-ethanol business in Brazil is founded."

 

- ENDS -

 

  

For further information, please contact:

 

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

 

Evolution Securities

Tavistock Communications

Tim Worlledge / Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk

 

 

 

About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company listed on the AIM market of the London Stock Exchange in July 2004. Ticker symbol is PHC.

 

PHC's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRATBMMTMBTMTFM
Date   Source Headline
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.